These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15937709)

  • 21. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth.
    Meyer JL; Thomas WC
    J Urol; 1982 Dec; 128(6):1376-8. PubMed ID: 7154211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium oxalate dihydrate formation in urine.
    Martin X; Smith LH; Werness PG
    Kidney Int; 1984 Jun; 25(6):948-52. PubMed ID: 6471675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of citrate complexes in preventing urolithiasis.
    Ashby RA; Sleet RJ
    Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.
    Grases F; Costa-Bauzá A; March JG; Masárová L
    Urol Res; 1991; 19(6):375-80. PubMed ID: 1759332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of calcium oxalate crystallization: theory, in vitro studies, and in vivo implementation.
    Rodgers A
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S351-4. PubMed ID: 10541262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical basis of the effects of Tamm-Horsfall protein on the formation of calcium oxalate stones].
    Deng F; Ouyang JM
    Wei Sheng Yan Jiu; 2006 Jan; 35(1):126-8. PubMed ID: 16598956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urolithiasis inhibitors and calculus nucleation.
    Grases F; Gil JJ; Conte A
    Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of glycosaminoglycans in tubular epithelial cells: calcium oxalate and oxalate ions effects.
    Borges FT; Michelacci YM; Aguiar JA; Dalboni MA; Garófalo AS; Schor N
    Kidney Int; 2005 Oct; 68(4):1630-42. PubMed ID: 16164640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis].
    Cifuentes Delatte L
    Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.